Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment - Multiple Myeloma: A POCN Center of Excellence

Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment

The International Myeloma Working Group developed practical recommendations for the diagnosis and management of multiple myeloma-related renal impairment (RI).

Reference: Dimopoulos M, Gastritis E, et al. International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment. Journal of Clinical Oncology. 2016.

Donna D. Catamero

ANP-BC, OCN, CCRC
Associate Director, Multiple Myeloma Research Program

Related Articles

Global Experts Tackle Infection Risks in Multiple Myeloma, Call for Unified Prevention Guidelines

FDA ODAC Backs Ide-Cel in Multiple Myeloma, Highlighting KarMMa-3 Trial Results

DREAMM-8 Trial: Belantamab Mafodotin Shows Promise in Treating Multiple Myeloma

FDA Panel Backs Cilta-cel for Relapsed/Refractory Multiple Myeloma Post-CARTITUDE-4 Success

Privacy Policy
Terms of Use

Company
Contact

Partner with Us
Ambassador Program

© 2024 Point of Care Network, LLC. All Rights Reserved.

Privacy Policy
Terms of Use
Company
Contact
Partner with Us
Ambassador Program

© 2022 Point of Care Network, LLC. All Rights Reserved.